ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 966 filers reported holding ASTRAZENECA PLC in Q1 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $898,082,905 | -7.1% | 13,261,705 | -1.8% | 0.09% | -4.2% |
Q2 2023 | $966,607,525 | +7.5% | 13,505,761 | +4.3% | 0.10% | -1.0% |
Q1 2023 | $899,001,810 | +29.7% | 12,952,048 | +26.7% | 0.10% | +21.5% |
Q4 2022 | $693,092,234 | +45.9% | 10,222,597 | +18.0% | 0.08% | +21.5% |
Q3 2022 | $474,992,000 | -14.3% | 8,661,403 | +3.3% | 0.06% | -9.7% |
Q2 2022 | $554,170,000 | +169.2% | 8,387,609 | +170.3% | 0.07% | +157.1% |
Q1 2022 | $205,830,000 | +11.0% | 3,102,653 | -2.5% | 0.03% | +21.7% |
Q4 2021 | $185,364,000 | -30.3% | 3,182,233 | -28.1% | 0.02% | -36.1% |
Q3 2021 | $265,774,000 | +2.6% | 4,425,151 | +2.4% | 0.04% | +5.9% |
Q2 2021 | $258,954,000 | +131.0% | 4,323,110 | +91.7% | 0.03% | +112.5% |
Q1 2021 | $112,100,000 | -10.3% | 2,254,630 | -9.8% | 0.02% | -15.8% |
Q4 2020 | $125,017,000 | -44.7% | 2,500,839 | -39.4% | 0.02% | -56.8% |
Q3 2020 | $226,231,000 | +14.0% | 4,128,296 | +10.1% | 0.04% | 0.0% |
Q2 2020 | $198,365,000 | +99.3% | 3,750,516 | +68.3% | 0.04% | +63.0% |
Q1 2020 | $99,542,000 | -10.7% | 2,228,900 | -0.3% | 0.03% | +3.8% |
Q4 2019 | $111,498,000 | +12.2% | 2,236,226 | +0.3% | 0.03% | 0.0% |
Q3 2019 | $99,403,000 | -1.0% | 2,230,273 | -8.3% | 0.03% | -3.7% |
Q2 2019 | $100,389,000 | -66.6% | 2,431,892 | -67.3% | 0.03% | -68.2% |
Q1 2019 | $300,552,000 | +254.9% | 7,433,887 | +233.4% | 0.08% | +240.0% |
Q4 2018 | $84,682,000 | -13.0% | 2,229,667 | -9.3% | 0.02% | +4.2% |
Q3 2018 | $97,321,000 | +18.9% | 2,459,458 | +5.5% | 0.02% | +9.1% |
Q2 2018 | $81,885,000 | -4.6% | 2,332,242 | -5.0% | 0.02% | -8.3% |
Q1 2018 | $85,827,000 | +1.4% | 2,454,298 | +0.6% | 0.02% | +4.3% |
Q4 2017 | $84,615,000 | +8.3% | 2,438,510 | +5.7% | 0.02% | 0.0% |
Q3 2017 | $78,141,000 | -8.4% | 2,306,408 | -7.8% | 0.02% | -11.5% |
Q2 2017 | $85,299,000 | -43.3% | 2,502,177 | -48.2% | 0.03% | +13.0% |
Q1 2017 | $150,530,000 | +22.5% | 4,833,956 | +7.5% | 0.02% | +15.0% |
Q4 2016 | $122,868,000 | +53.5% | 4,497,398 | +84.6% | 0.02% | -25.9% |
Q3 2016 | $80,069,000 | +25.4% | 2,436,679 | +15.2% | 0.03% | +17.4% |
Q2 2016 | $63,851,000 | +14.2% | 2,114,997 | +6.5% | 0.02% | +4.5% |
Q1 2016 | $55,905,000 | +4.7% | 1,985,260 | +26.3% | 0.02% | +15.8% |
Q4 2015 | $53,382,000 | +24.1% | 1,572,388 | +16.3% | 0.02% | +18.8% |
Q3 2015 | $43,008,000 | +3.3% | 1,351,601 | +106.7% | 0.02% | +14.3% |
Q2 2015 | $41,652,000 | -12.6% | 653,780 | -6.2% | 0.01% | -22.2% |
Q1 2015 | $47,674,000 | -24.2% | 696,693 | -22.1% | 0.02% | -21.7% |
Q4 2014 | $62,935,000 | -52.1% | 894,207 | -51.4% | 0.02% | -54.9% |
Q3 2014 | $131,522,000 | -25.0% | 1,841,013 | -22.0% | 0.05% | -26.1% |
Q2 2014 | $175,360,000 | +208.9% | 2,359,854 | +169.7% | 0.07% | +187.5% |
Q1 2014 | $56,761,000 | -16.2% | 874,853 | -23.3% | 0.02% | -17.2% |
Q4 2013 | $67,743,000 | +31.8% | 1,141,041 | +15.2% | 0.03% | +20.8% |
Q3 2013 | $51,415,000 | +17.5% | 990,098 | +7.0% | 0.02% | +9.1% |
Q2 2013 | $43,760,000 | – | 925,190 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 611,665 | $35,629,000 | 8.68% |
SPHERA FUNDS MANAGEMENT LTD. | 1,055,467 | $61,481,000 | 6.76% |
Endurant Capital Management LP | 324,728 | $18,915,000 | 4.57% |
Darwin Global Management, Ltd. | 511,908 | $29,819,000 | 4.56% |
SAL Trading, LLC | 188,276 | $10,967,000 | 4.47% |
Susquehanna International Securities, Ltd. | 126,356 | $7,360,000 | 4.45% |
ARDSLEY ADVISORY PARTNERS LP | 400,000 | $23,300,000 | 4.44% |
Avidity Partners Management LP | 2,867,200 | $167,014,000 | 3.54% |
Eversept Partners, LP | 949,224 | $55,292,298 | 3.53% |
GQG Partners LLC | 19,453,752 | $1,132,984,000 | 2.81% |